The anti-angiogenic 8-epipuupehedione behaves as a potential anti-leukaemic compound against HL-60 cells

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 2, 2008, Pages 701-706

  Martínez Poveda, Beatriz ^a   Quesada, Ana R ^a,b   Medina, Miguel Ángel ^a,b  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b ClBERER   (Spain)

Author keywords

8 epipuupehedione; Apoptosis; Matrix metalloproteinase 2; Promyelocytic leukaemia; Urokinase, angiogenesis

Indexed keywords

8 EPIPUUPEHEDIONE; 8-EPIPUUPEHEDIONE; ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT; CASPASE 3; GELATINASE A; MMP2 PROTEIN, HUMAN; TERPENE; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL; AORTA; APOPTOSIS; ARTICLE; CATTLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN HL 60; CELL SURVIVAL; CYTOLOGY; DNA FRAGMENTATION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; IC 50; METABOLISM; PROMYELOCYTIC LEUKEMIA; TIME; VASCULAR ENDOTHELIUM;

ANGIOGENESIS INHIBITORS; ANIMALS; ANTINEOPLASTIC AGENTS; AORTA; APOPTOSIS; CASPASE 3; CATTLE; CELL CYCLE; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HL-60 CELLS; HUMANS; INHIBITORY CONCENTRATION 50; LEUKEMIA, PROMYELOCYTIC, ACUTE; MATRIX METALLOPROTEINASE 2; TERPENES; TIME FACTORS; URINARY PLASMINOGEN ACTIVATOR;

EID: 42349087979     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2007.00134.x     Document Type: Article

References (18)

1. Hussong JW, Rodgers GM, Shami PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood. 2000 95 : 309 13.
2. Kini AR, Peterson LA, Tallman MS, Lingen MW. Angiogenesis in acute promyelocytic leukemia: induction by vascular endothelial growth factor and inhibition by all-trans retinoic acid. Blood. 2001 97 : 3919 24.
3. Molica S, Vacca A, Levato D, Merchionne E, Ribatti D. Angiogenesis in acute and chronic lym-phocytic leukemia. Leuk Res. 2004 28 : 1239 40.
4. Kini AR. Angiogenesis in leukemia and lymphoma. Cancer Treat Res. 2004 121 : 221 38.
5. Letilovic T, Vrhovac R, Verstovsek S, Jaksic B, Ferrajoli A. Role of angiogenesis in chronic lympho-cytic leukemia. Cancer. 2006 107 : 925 34.
6. Quesada AR, Muñoz-Chápuli R, Medina MA. Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev. 2006 26 : 483 530.
7. Muñoz-Chápuli R, Quesada AR, Medina MA. Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci. 2004 61 : 2224 43.
8. Medina MA, Muñoz-Chápuli R, Quesada AR. Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope. J Cell Mol Med. 2007 11 : 374 82.
9. Martínez-Poveda B, Quesada AR, Medina MA. Hyperforin, a bioactive compound of St. John's wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Int J Cancer. 2005 117 : 775 80.
10. Quiney C, Billard C, Mirshahi O, Fourneron JD, Kolb JP. Hyperforin inhibits MMP-9 secretion by B-CLL cells and microtubule formation by endothelial cells. Leukemia. 2006 20 : 583 9.
11. Alimoghaddam K, Shariftabrizi A, Tavangar SM, Sanaat Z, Rostami S, Jahani M, Ghavamzadeh A. Anti-leukemic and anti-angiogenesis efficacy of arsenic trioxide in new cases of acute promyeolocyt-ic leukemia. Leuk Lymphoma. 2006 47 : 81 8.
12. Castro ME, González-Iriarte M, Barrero AF, Salvador-Tormo N, Muñoz-Chápuli R, Medina MA, Quesada AR. Study of puupehenone and related compounds as inhibitors of angiogenesis. Int J Cancer. 2004 110 : 31 8.
13. Barrero AF, Álvarez-Miranda EJ, Chahboun R, Cortés M, Armstrong V. Synthesis and antitumor activity of puupehedione and related compouns. Tetrahedron. 1999 55 : 15181 95.
14. Gospodarowicz D, Moran J, Braun D, Birdwell C. Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci USA. 1976 73 : 4120 4.
15. Fajardo I, Urdiales JL, Sánchez-Jiménez F, Medina MA. An experiment on apoptosis induced by polyamine adducts produced in the presence of serum amine oxidase. Biochem Educ. 2000 28 : 110 2.
16. García de Vea R, Schweigerer L, Medina MA. Modulation of the proteolytic balance plasminogen activator/plasminogen activator inhibitor by enhanced N-myc oncogene expression or application of genistein. Eur J Cancer. 1998 34 : 1736 40.
17. Fajardo I, Quesada AR, Núñez de Castro I, Sánchez-Jiménez F, Medina MA. A comparative study of the effects of genistein and 2-methoxyestra-diol on the proteolytic balance and tumour cell proliferation. Br J Cancer. 1999 80 : 17 24.
18. Gazzanelli G, Luchetti F, Burattini S, Mannello F, Falcieri E, Papa S. Matrix metalloproteinases expression in HL-60 promyelocytic leukemia cells during apoptosis. Apoptosis. 2000 5 : 1656 72.